Standout Papers

Ranibizumab for Macular Edema following Central Retinal Vein Oc... 2002 2026 2010 2018 907
  1. Ranibizumab for Macular Edema following Central Retinal Vein Occlusion (2010)
    David M. Brown, Peter A. Campochiaro et al. Ophthalmology
  2. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1 (2002)
    Nicholas W. Gale, Gavin Thurston et al. Developmental Cell
  3. Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion (2010)
    Peter A. Campochiaro, Jeffrey S. Heier et al. Ophthalmology
  4. Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study (2011)
    Peter A. Campochiaro, David M. Brown et al. Ophthalmology
  5. Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 (2003)
    Brian Kelly, Sean F. Hackett et al. Circulation Research
  6. Molecular pathogenesis of retinal and choroidal vascular diseases (2015)
    Peter A. Campochiaro Progress in Retinal and Eye Research
  7. Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study (2011)
    David M. Brown, Peter A. Campochiaro et al. Ophthalmology
  8. Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema (2012)
    Peter A. Campochiaro, David M. Brown et al. Ophthalmology
  9. Ranibizumab for Macular Edema Due to Retinal Vein Occlusions (2012)
    Jeffrey S. Heier, Peter A. Campochiaro et al. Ophthalmology
  10. Ocular neovascularization (2013)
    Peter A. Campochiaro Journal of Molecular Medicine
  11. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion (2014)
    Peter A. Campochiaro, W. Lloyd Clark et al. Ophthalmology
  12. The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration (2019)
    Peter A. Campochiaro, Dennis M. Marcus et al. Ophthalmology
  13. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study (2024)
    Peter A. Campochiaro, Robert L. Avery et al. The Lancet

Immediate Impact

67 by Nobel laureates 31 from Science/Nature 106 standout
Sub-graph 1 of 19

Citing Papers

A systems view of the vascular endothelium in health and disease
2024 Standout
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
58 intermediate papers

Works of Peter A. Campochiaro being referenced

Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood–retinal barrier
2004
Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1
2002 Standout
and 56 more

Author Peers

Author Last Decade Papers Cites
Peter A. Campochiaro 18793 13129 11110 366 28.2k
Alan C. Bird 17762 10879 10091 348 24.4k
David R. Hinton 5571 8841 3506 381 20.4k
Joan W. Miller 11048 6710 6458 366 16.1k
Nagahisa Yoshimura 16555 5824 11505 552 21.3k
Lois E. H. Smith 5860 5580 7468 216 16.2k
Peter Wiedemann 7654 6578 4865 410 13.8k
Abbot F. Clark 8908 6355 3119 228 12.4k
Chi‐Chao Chan 9058 4571 2383 394 18.1k
Jian‐xing Ma 4279 7368 1993 289 11.8k
Hidenobu Tanihara 5908 4733 2844 271 10.2k

All Works

Loading papers...

Rankless by CCL
2026